HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dihydroxyacetone

This article was originally published in The Rose Sheet

Executive Summary

Self-tanning ingredient nominated for National Toxicology Program skin absorption studies due to carcinogenicity concerns, NTP announces in the May 28 Federal Register. NTP is requesting that public comment and research be submitted within 60 days of the notice. The National Cancer Institute nominated the ingredient for testing. At the close of the comment period, a summary of the Interagency Committee for Chemical Evaluation and Coordination recommendation for testing and public comments will be presented to the NTP Board of Scientific Counselors -- the program's external scientific advisory committee -- in an open public hearing. DHA is used in all cosmetic self-tanners, according to NTP, including Estee Lauder's Clinique Self-Tanning Cream, Clarins Self Tanning Treatments, Schering-Plough's Coppertone Protect & Tan and Freeman Beautiful Skin Sun Care Self Tanner...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005455

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel